ALDH1L2 and metabolic syndrome: For example, elevated plasma levels of C3 and C5 acylcarnitines, the phenomenon linked to the ALDH1L2 loss, could be associated with obesity, metabolic syndrome, insulin resistance, and type 2 diabetes [49, 50].